全文获取类型
收费全文 | 28787篇 |
免费 | 1578篇 |
国内免费 | 167篇 |
专业分类
耳鼻咽喉 | 293篇 |
儿科学 | 632篇 |
妇产科学 | 689篇 |
基础医学 | 3659篇 |
口腔科学 | 1079篇 |
临床医学 | 2181篇 |
内科学 | 7642篇 |
皮肤病学 | 749篇 |
神经病学 | 2146篇 |
特种医学 | 538篇 |
外科学 | 4589篇 |
综合类 | 184篇 |
一般理论 | 3篇 |
预防医学 | 2139篇 |
眼科学 | 488篇 |
药学 | 1615篇 |
中国医学 | 147篇 |
肿瘤学 | 1759篇 |
出版年
2023年 | 235篇 |
2022年 | 495篇 |
2021年 | 1110篇 |
2020年 | 506篇 |
2019年 | 1020篇 |
2018年 | 1145篇 |
2017年 | 647篇 |
2016年 | 668篇 |
2015年 | 830篇 |
2014年 | 1211篇 |
2013年 | 1479篇 |
2012年 | 2336篇 |
2011年 | 2388篇 |
2010年 | 1416篇 |
2009年 | 1210篇 |
2008年 | 1918篇 |
2007年 | 1958篇 |
2006年 | 1802篇 |
2005年 | 1611篇 |
2004年 | 1488篇 |
2003年 | 1423篇 |
2002年 | 1316篇 |
2001年 | 186篇 |
2000年 | 163篇 |
1999年 | 193篇 |
1998年 | 199篇 |
1997年 | 160篇 |
1996年 | 153篇 |
1995年 | 132篇 |
1994年 | 107篇 |
1993年 | 86篇 |
1992年 | 85篇 |
1991年 | 60篇 |
1990年 | 65篇 |
1989年 | 50篇 |
1988年 | 48篇 |
1987年 | 46篇 |
1986年 | 26篇 |
1985年 | 42篇 |
1984年 | 41篇 |
1983年 | 41篇 |
1982年 | 51篇 |
1981年 | 49篇 |
1980年 | 46篇 |
1979年 | 23篇 |
1978年 | 28篇 |
1977年 | 29篇 |
1976年 | 21篇 |
1975年 | 23篇 |
1974年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
961.
Luis M. De Leon-Rodriguez Young-Eun Park Dorit Naot David S. Musson Jillian Cornish Margaret A. Brimble 《RSC advances》2020,10(31):18222
The use of peptide hydrogels is of growing interest in bone regeneration. Self-assembling peptides form hydrogels and can be used as injectable drug delivery matrices. Injected into the defect site, they can gel in situ, and release factors that aid bone growth. We report on the design, synthesis and characterization of three β-hairpin peptide hydrogels, and on their osteoblast cytocompatibility as well as delivery of the lactoferrin glycoprotein, a bone anabolic factor. Osteoblasts cultured in hydrogels of the peptide with sequence NH2-Leu-His-Leu-His-Leu-Lys-Leu-Lys-Val-dPro-Pro-Thr-Lys-Leu-Lys-Leu-His-Leu-His-Leu-Arg-Gly-Asp-Ser-CONH2 (H4LMAX-RGDS) increased the osteoblast cell number and the cells appeared healthy after seven days. Furthermore, we showed that H4LMAX-RGDS was capable of releasing up to 60% of lactoferrin (pre-encapsulated in the gel) over five days while retaining the rest of the glycoprotein. Thus, H4LMAX-RGDS hydrogels are cytocompatible with primary osteoblasts and capable of delivering bio-active lactoferrin that increases osteoblast cell number.Self-assembling peptide H4LMAX-RGDS hydrogels, designed to enhance bone regeneration, are cytocompatible and capable of delivering the bone anabolic factor lactoferrin to increase osteoblast cell number. 相似文献
962.
Jos-Ramn Blanco Ramn Morillo Vicente Abril Ismael Escobar Enrique Bernal Carlos Folguera Ftima Braas Mercedes Gimeno Olatz Ibarra Jos-Antonio Iribarren Alicia Lzaro Ana Mario Mara-Teresa Martn Esteban Martinez Luis Ortega Julian Olalla Aguas Robustillo Matilde Sanchez-Conde Miguel-Angel Rodriguez Javier de la Torre Javier Sanchez-Rubio Montse Tuset 《European journal of clinical pharmacology》2020,76(3):305-318
963.
964.
965.
Guido Basilisco Giovanni Barbara Massimo Bellini Giovanni Cataudella Lucia D’Alba Michele Guarino Paola Iovino Maria Cristina Neri Giovanni Sarnelli Edoardo Savarino Salvatore Tolone Francesco Torresan Paolo Usai-Satta Ambra Lovati Elena Arsiè Marina Coletta 《Alimentary pharmacology & therapeutics》2020,51(9):910-911
966.
967.
968.
Luis A. González Yulieth A. Upegui Luis Rivas Fernando Echeverri Gustavo Escobar Sara M. Robledo Wiston Quiñones 《Archiv der Pharmazie》2020,353(12):2000157
Chalcones are a group of natural products with many recognized biological activities, including antiparasitic activity. Although a lot of chalcones have been synthetized and assayed against parasites, the number of structural features known to be involved in this biological property is small. Thus, in the present study, 21 chalcones were synthesized to determine the effect of substituents in the A and B rings on the activity against Leishmania braziliensis, Trypanosoma cruzi, and Plasmodium falciparum. The compounds were active against L. braziliensis in a structure-dependent manner. Only one compound was very active against T. cruzi, but none of them had a significant antiplasmodial activity. The electron-donating substituents in ring B and the hydrogen bonds at C-2′ with carbonyl affect the antiparasitic activity. 相似文献
969.
Marcelo Borghi Ezequiel Becher Marcelo Bou Luis Montes de Oca Juan Fernandez Long Luisa Rafailovici Luisa Filomia Edgardo F. Becher 《Brachytherapy》2019,18(4):462-469
PurposeImplanted rectal spacers (IRS) have been developed to increase the distance between the prostate and the rectum, thus optimizing dose escalation. Cost is a disadvantage and there are still uncertainties as to their durability. We have developed an autologous fat transfer (AFT) technique to use as an IRS. We aim to present the feasibility and durability at 6 months of AFT placed immediately after the implant of the seeds in low-dose-rate brachytherapy (BT).Methods and MaterialsThirty-five patients underwent AFT (12 were treated with primary BT, 7 with a combined primary treatment of external beam radiotherapy + BT, 16 with salvage BT). The isodose used for primary BT was 14400 cGy, 11,000 cGy after 4600 cGy of external beam radiotherapy in the combined group, and 14400 cGy for the salvage group. Patients underwent a CT scan at 1, 3, and 6 months to measure the distance between the rectum and the prostate.ResultsAn average of 32.7 cc (20–40) of fat was transferred successfully in 100% of cases. The mean distance to the rectum at the level of the base, middle, and apex at 1 and 6 months were 11.2, 9.7, and 7.6 mm; 8.3, 8.1, and 5.9 mm, respectively. No rectal toxicity or major complications were reported.ConclusionsThe use of fat as an IRS seems to be a valid alternative to reduce rectal toxicity after BT, achieving equivalent distances to synthetic IRS. It is feasible, safe, and the loss of distance at 6 months is small. Cost is lower than other alternatives. 相似文献
970.
Jesús Aldea Martínez Laura Aldea Viana José Luis López Martínez Enrique Ruiz Pérez 《Journal of vascular and interventional radiology : JVIR》2019,30(10):1567-1573
PurposeTo evaluate the volume reduction rate (VRR) of thyroid nodules over a long period of time after radiofrequency (RF) ablation treatment in both solid and mixed nodules; to determine ablation parameters; and to evaluate complications and success rates and safety of RF ablation.Material and MethodsIn this prospective study, 24 patients (83% females and 17% males; age 50.17 ± 13.6 years) underwent ultrasound-guided percutaneous RF ablation of benign thyroid nodules with radiologic follow-up at 1, 3, 6, 12, 24, and 36 months after treatment. All patients presented with compressive or cosmetic complaints and with Thyroid Imaging Reporting and Data System 1 or 2 nodules under ultrasound and were confirmed to be Bethesda Category II after 2 fine-needle aspirations.ResultsA total of 24 nodules (54.2% solid, 37.5% solid predominance, and 8.3% cystic predominance) were included in this study. Significant results in VRR (%) were found at 24 months and 36 months of 69.92 ± 19.23 and 76.84 ± 15.92, respectively. Furthermore, a logarithmic relationship was found when VRR was plotted over time, in both solid and mixed nodules. No correlations were found with any of the ablation parameters. The success rate reached 72.22% at 12 months, and the total complication rate was 16.67% (12.5% minor complications and 4.2% major complications—1 laryngeal nerve palsy), reaching an 83.3% safety.ConclusionsRF ablation can be an alternative treatment modality in the management of benign symptomatic thyroid nodules. The results show that it is a safe and effective treatment if trans-isthmic approach and moving-shot techniques are correctly followed. 相似文献